Indication
Bone Diseases
3 clinical trials
4 products
1 drug
Clinical trial
A Multicenter, Randomized, Controlled, Non-inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple MyelomaStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Product
NarlumosbartProduct
DenosumabClinical trial
The Role of Akkermansia Muciniphilia in Combating the Metabolic Effects of Androgen Deprivation Therapy in Men With Metastatic Prostate CancerStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Product
Apple Cider VinegarDrug
VarlilumabClinical trial
Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Kidney Disease Progression and Bone Mineral Metabolism in Non-diabetic Patients With Chronic Kidney DiseaseStatus: Active (not recruiting), Estimated PCD: 2023-11-10
Product
Dapagliflozin